Plus therapeutics to present at the canaccord genuity 43rd annual growth conference

Austin, texas, aug. 03, 2023 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system cancers, announced today that marc hedrick, m.d., president and chief executive officer, has been invited to present at the canaccord genuity 43rd annual growth conference, on wednesday, august 9, 2023 at 8:00 a.m. et at the intercontinental boston in boston, mass.
pstv Ratings Summary
pstv Quant Ranking